Crewe Advisors LLC Insulet Corp Transaction History

Crewe Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$272.48 - $330.23 $5,722 - $6,934	-21 Reduced 95.45%	1 $0
Q4 2022 Feb 07, 2023	SELL	$212.22 - $313.46 $4,456 - $6,582	-21 Reduced 48.84%	22 $6,000
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $1,572 - $1,970	7 Added 19.44%	43 $10,000
Q2 2022 Aug 02, 2022	BUY	$186.4 - $279.02 $6,710 - $10,044	36 New	36 $8,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.